Skip to main content

Peer Review reports

From: Incidence of heart valve disease in women treated with the ergot-derived dopamine agonist bromocriptine

Original Submission
29 Jan 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
4 Oct 2021 Reviewed Reviewer Report - Christoph Sinning
5 Nov 2021 Reviewed Reviewer Report - Craig E. Stiles
6 Dec 2021 Author responded Author comments - Søren Lund Kristensen
Resubmission - Version 3
6 Dec 2021 Submitted Manuscript version 3
Publishing
17 Dec 2021 Editorially accepted
28 Dec 2021 Article published 10.1186/s12872-021-02439-y

You can find further information about peer review here.

Back to article page